Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines

Cell Growth and Differentiation

Volumn 12, Issue 6, 2001, Pages 327-335

  Goodwin, B L ^a   Xi, H ^a   Tejiram, R ^a   Eason, D D ^a   Ghosh, N ^a   Wright, K L ^a   Nagarajan, U ^a   Boss, J M ^a   Blanck, G ^a  

^a MDC 7 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CARCINOGENESIS; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY;

DNA-BINDING PROTEINS; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOST CELL FACTOR C1; HUMANS; INTERFERON TYPE II; MELANOCYTES; MELANOMA; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-1; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034919665     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts
2. Sequences and factors: A guide to MHC class-II transcription
3. Current concepts in DRA gene regulation
4. Regulation of MHC class II genes: Lessons from a disease
5. Regulation of class II MHC expression
6. Regulation of MHC gene regulation
7. Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression
8. Surface antigens of melanocytes and melanomas: Markers of melanocyte differentiation and melanoma subsets
9. Changes in la-like antigen expression on malignant human cells
10. DR (la-like) antigens on human melanoma cells. Serological detection and immuno-chemical characterization
11. Immune response to autologous human melanoma: Implication of class I and II MHC products
12. The EORTC Melanoma Group exchange program: Evaluation of a multicenter monoclonal antibody study
13. Surface antigens of melanomas and melanocytes defined by mouse monoclonial antibodies: Specificity analysis and comparison of antigen expression in cultured cells and tissues
14. Antigenic profile of tumor progression states in human melanocytic nevi and melanomas
15. Surface antigens of melanoma and melanocytes: Specificity of induction of la antigens by human γ-interferon
16. Molecular analysis of HLA-DR gene expression induced by IFN-γ in malignant melanoma cell lines
17. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma
18. DNA content and MHC class II antigen expression in malignant melanoma: Clinical course
19. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma
20. The initial steps of tumor progression in melanocytic lineages: A histochemical approach
21. Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?
22. MHC class II-mediated antigen presentation by melanoma cells
23. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
24. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA
25. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo
26. Class II transactivator. Mastering the art of major histocompatibility complex expression
27. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
28. Two distinct γ interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by Stat1, interferon regulatory factor 1, and transforming growth factor β
29. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, interferon-γ, STAT1, and TGF-β regulated expression of the class II transactivator gene
30. A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes
31. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2
32. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction of STAT1 and USF
33. Chlamydia inhibits Interferon-γ-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1
34. GAS elements: A few nucleotides with a major impact on cytokine-induced gene expression
35. Immunoelectron microscopic identification of Langerhans cells using a new antigenic marker
36. Human melanoma: Development and progression
37. γ-interferon induction of HLA class II mRNAs in dermal fibroblasts studied by RNase protection analysis
38. Apoptosis independent retinoblastoma protein rescue of HLA class II mRNA IFN-β inducibility in non-small cell lung carcinoma: Lack of surface HLA-DR expression associated with a specific defect in HLA-DRA induction
39. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
40. Human interferon regulatory factor 2 gene: Intron-exon organization and function analysis of 5′-flanking region